Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids.
Blackburn DJ, Krishnan K, Fox L, Ballard C, Burns A, Ford GA, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw J, Bath PM. Blackburn DJ, et al. Among authors: reckless j. Trials. 2013 Nov 22;14:401. doi: 10.1186/1745-6215-14-401. Trials. 2013. PMID: 24266960 Free PMC article. Clinical Trial.
Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.
Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw JM, Ford GA; PODCAST Trial Investigators. Bath PM, et al. Among authors: reckless j. PLoS One. 2017 Jan 17;12(1):e0164608. doi: 10.1371/journal.pone.0164608. eCollection 2017. PLoS One. 2017. PMID: 28095412 Free PMC article. Clinical Trial.
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group; Armitage J, Bowman L, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Peto R, Collins R. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, et al. Lancet. 2010 Nov 13;376(9753):1658-69. doi: 10.1016/S0140-6736(10)60310-8. Epub 2010 Nov 8. Lancet. 2010. PMID: 21067805 Free PMC article. Clinical Trial.
Empowering primary care to tackle the obesity epidemic: the Counterweight Programme.
McQuigg M, Brown J, Broom J, Laws RA, Reckless JP, Noble PA, Kumar S, McCombie EL, Lean ME, Lyons GF, Frost GS, Quinn MF, Barth JH, Haynes SM, Finer N, Ross HM, Hole DJ; Counterweight Project Team. McQuigg M, et al. Among authors: reckless jp. Eur J Clin Nutr. 2005 Aug;59 Suppl 1:S93-100; discussion S101. doi: 10.1038/sj.ejcn.1602180. Eur J Clin Nutr. 2005. PMID: 16052202
Cost-effectiveness of statins.
Reckless JP. Reckless JP. Curr Opin Lipidol. 2000 Aug;11(4):351-6. doi: 10.1097/00041433-200008000-00002. Curr Opin Lipidol. 2000. PMID: 10945715 Review.
Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
Reckless JP, Henry P, Pomykaj T, Lim ST, Massaad R, Vandormael K, Johnson-Levonas AO, Lis K, Brudi P, Allen C. Reckless JP, et al. Int J Clin Pract. 2008 Apr;62(4):539-54. doi: 10.1111/j.1742-1241.2008.01697.x. Epub 2008 Feb 11. Int J Clin Pract. 2008. PMID: 18266852 Clinical Trial.
Fluvastatin.
Lawrence JM, Reckless JP. Lawrence JM, et al. Among authors: reckless jp. Expert Opin Pharmacother. 2002 Nov;3(11):1631-41. doi: 10.1517/14656566.3.11.1631. Expert Opin Pharmacother. 2002. PMID: 12437496 Review.
174 results